España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
JPMorgan
Texas Instruments Recovery On Track As Analysts Monitor Industrial Sector Trends
Netflix Stock 'Firing On All Cylinders': 10 Analysts React To Q4 Beat, Guidance, Price Increases
Sun Country Airlines Wins JPMorgan Bullish View On Revenue Diversity
Netflix Stock 'Firing On All Cylinders': 10 Analysts React To Q4 Beat, Guidance, Price Increases
Sun Country Airlines Wins JPMorgan Bullish View On Revenue Diversity
US Stocks Set To Open On A Positive Note As Trump's Second White House Term Kicks Off: Tesla, Apple, Netflix Among Stocks In Focus
Box Office Set For $9.5 Billion 2025 Comeback As Netflix Reshapes Industry, Analyst Says
US Stocks Set To Open On A Positive Note As Trump's Second White House Term Kicks Off: Tesla, Apple, Netflix Among Stocks In Focus
Box Office Set For $9.5 Billion 2025 Comeback As Netflix Reshapes Industry, Analyst Says
Plug Power's 'Longer-Term Backstop' Is Here, But Execution Is Key: Analyst
ChargePoint Outpaces Tesla In EV Network Market Share, But JPMorgan Stays Cautious
Read More...
JPMorgan Recent News
Solana, XRP ETFs Could Outperform Ethereum ETFs, Says JPMorgan
Banking giant JPMorgan forecasts significant investments in Solana (CRYPTO: SOL) and XRP (CRYPTO: XRP) exchange-traded funds (ETFs) if they receive approval. The report, shared on Jan.
LegalZoom Gets Double Upgrade On 'Incrementally Positive' Business Formations Data
LegalZoom.com Inc (LZ) could benefit from positive trend in business formations, as per JPMorgan analyst. Upgraded rating to Overweight, PT $9.
Jamie Dimon Says He's Not Against Blockchains But Trades Guns On Bitcoin Again—It Has No Intrinsic Value: 'I Just Don't Feel Great About...'
Jamie Dimon, the CEO of banking behemoth JPMorgan, reiterated his critical stance on Bitcoin (CRYPTO: BTC) while recognizing the importance of blockchain technology.
Mohawk Industries Is An Inexpensive Way To Play The Rebound In Repair/Remodel Demand, Says Bullish Analyst
Analyst bullish on Mohawk Industries as it is trading at a discount and has potential for margin drivers and strong balance sheet. Cheaper way to play repair/remodel demand rebound.
What's Going On With Marvell Technology (MRVL) Stock?
Marvell Technology shares are trading higher by some 7% over the trailing week. JPMorgan analyst Harlan Sur highlights Marvell's strong AI-driven growth momentum.
Jamie Dimon Questioned Bitcoin's 21 Million Cap Years Before BlackRock — Here's How Much You'd Have If You Invested $1,000 Into BTC When JPMorgan CEO Shared His Take
The world’s largest asset manager, BlackRock, kicked up a storm last month after supposedly disputing Bitcoin's (CRYPTO: BTC) supply cap in one of its explai
JPMorgan Sees Marvell's AI Revenue Surge With $2 Billion Run-Rate In Networking By 2025
The JPMorgan analyst shared Marvell Technology is on track to exceed its AI target of $2.5B by 2025, with strong performance in optical/copper networking and partnerships with Amazon.
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.
Here's How Trump Could Wipe Out 40% of Tesla's Profits After Taking Office, According To JPMorgan Analyst
The profitability of Tesla Inc. could be severely impacted under the second Trump administration, with a potential 40% decrease.
Dollar Strength To Be Driven By Trump's Deregulation, Tariff And Tax Policies In 2025 After A Strong 2024
Wall Street is anticipating the US Dollar's momentum to continue in 2025 as Trump's proposed tax cuts and tariff hikes act as a tailwind.
Steve Jobs Knew What MacBook Should Be Like In 1983 — It Took Apple 25 Years To Bring His Vision To Life: With AAPL Stock At Record Highs, Here's What Analysts Say
Steve Jobs is credited for his visionary leadership and for revolutionizing entire product categories, ranging from smartphones to tablets and music.
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
The year 2024 saw the U.S. stock market make new records, with major indices breaching key milestones. While many stocks witnessed a stellar rally this year, analysts still expect some blue-chip equities to rise further as they forecast a better return potential. Dow’s Performance In 2024
Big Lots Holds Liquidation Sales, Analyst Pegs Competitor As Major Beneficiary: 'Market Share Capture Opportunity'
Big Lots filed for Chapter 11 bankruptcy and announced a sale of assets to Nexus Capital. Competitor Ollie's Bargain may gain market share from store closures.
Nike Stock Turnaround Path Clear, Analyst Says: 'Getting Back To Winning Takes Time'
The Nike turnaround plan could take longer than expected, but early signs of a comeback are there. Here's what 7 analysts said after Q2 results.
Streamers Max, Paramount+ Won November: Here's Why Analyst Expects Netflix, Amazon To Win December
JPMorgan analysts pick the winners for the streaming sector in November based on downloads and user activity and look ahead to December.
How To Invest $1,000 In Regional Banks For 2025: Top Wall Street Analyst Reveals His Top Picks
According to JPMorgan, regional bank stocks have strong potential for gains in 2025, driven by pro-business policies, rate cuts, and M&A activity.
JPMorgan Downgrades Editas Medicine, Says Focus Shift Sparks Investor Caution
Editas Medicine pivots to in vivo gene editing, extends cash runway to 2027, but faces investor caution amid unclear proof-of-concept timelines.
Teradyne Rises After Analyst's Upbeat Forecast For 2025 Growth
Teradyne (TER) stock climbed as JPMorgan upgrades with increased price target and predicts strong revenue growth due to expanding semiconductor market.
NetApp Is Poised For Revenue Growth Acceleration With AI Spending: Analyst
JPMorgan analyst Samik Chatterjee upgraded the rating for NetApp from Neutral to Overweight, while raising the price target to $160.
Gold Poised For Its Best Year In A Decade While Bitcoin Surges: Analysts Eye 2025 As A Golden Era For Precious Metal Amid Michael Saylor's Push For BTC As A Reserve Asset
Analysts predict a good year for gold in 2025 after it’s poised for the best annual performance in over a decade in 2024.
Penn Stock Analyst Turns Bullish On ESPN Bet Strength, Casino Improvements: 'Favorable Risk-Reward'
Penn Entertainment offers a compelling risk-reward for the future, an analyst says highlighting the ESPN Bet segment and improvements to casino projects.
MKS Instruments Is 'Gaining Traction' In Advanced Technologies, Analyst Says
MKS Instruments initiated by JPMorgan analyst (Overweight with $145 target). It will benefit from WFE trends and market share gains.
Adobe Analysts Split After Strong Q4, Weak 2025 Guidance
Adobe Inc's shares tanked despite upbeat Q4 results amid exciting earnings season. Piper Sandler, Oppenheimer, Goldman Sachs remain bullish.